You may qualify for a research study at the Wellman Center for Photomedicine at Massachusettts General Hospital investigating the efficacy of laser tattoo removal techniques.
- * You are an adult between the ages of 18 and 50
- * Your tattoo is not on your neck or face
- * The size of your tattoo is bigger than a matchbook and smaller than a
piece of paper
Participants can expect significant lightening of a tattoo.
If interested, please contact:
Kimberli Bell: (617) 724-4937
Does your baby have infantile hemangioma?
Your baby may qualify for a RESEARCH STUDY to evaluate the safety and effectiveness of two treatments that may prevent growth of hemangiomas – pulsed-dye laser treatment, and timolol maleate 0.5% opthalmic solution topical treatment for very early infantile hemangiomas. Pulsed-dye laser is widely used in children, and is approved by the FDA for treating hemangioma. This procedure has a few minor side effects that are most often temporary. Timolol is used frequently for the treatment of childhood glaucoma with few side effects, and has been shown to be effective in treating a case of hemangioma in infant. It is not yet an approved treatment for hemangioma. An important question being tested in this study is whether these treatments can prevent hemangioma from growing, when used very early after the birth of your child.
- * Your infant is less than 3 months, male or female
- * Your infant has one or more superficial hemangiomas in the very early stage
- * Your infant has no severe heart, asthma or lung disease
- * Your infant is not on any other treatment for the hemangioma
- * Photos, measurements, and treatment with either pulsed-dye laser or timolol or
- * Up to 13 study visits, less than 1 hour each, over two years period
- * Up to $385 in compensation for time and travel (parking sticker will also be
For more information, please email:
or call (617) 724-4937
Do you have a CESAREAN SECTION SCAR?
You may qualify for a RESEARCH STUDY using an FDA-approved laser procedure that may improve the appearance and feel of your scar. Some of the side effects include pain, burning sensation during the procedure, and redness, tenderness, and swelling after the procedure.
This is a study that aims to investigate genetic activity in treated versus untreated scars.
If you are a healthy female ages 18 to 50 years old:
Cesarean section scar
Skin biopsies will be asked
4 study visits over 10 weeks
More information can be found at:
Please e-mail: or
Or call: (617) 724-4937 or (617) 724-5329
Acne on your back or face?
Clinical Study Unit at Wellman Center for Photomedicine, Department of Dermatology, Massachusetts General Hospital is seeking for Healthy Volunteers for an Acne study.
Healthy volunteer study
Do you have ACNE ON YOUR BACK or ON YOUR FACE?
You may qualify for a RESEARCH STUDY of a use of an investigational light-based treatment called photodynamic therapy (PDT) using a drug called Levulan® followed by a light treatment (ALA-PDT). Levulan® is FDA-approved drug for precursors of skin cancer, called actinic keratosis (AK) (sun-related pre-cancer in the skin) but not for acne treatment. Levulan® is absorbed by normal skin surrounding the oil glands. Therefore, this procedure also has some side effects. Some of the side effects include pain, burning sensation during the procedure, and redness, tenderness, and swelling after the procedure.
This is a study that will compare “ALA-PDT” for acne versus a new investigational method, called “i-PDT”. i-PDT is intended to reduce side-effects of ALA-PDT treatment. i-PDT is also not FDA-approved for acne treatment.
If you are a healthy male/female ages 18 to 50 years old
Difficult to treat acne
Photos, questionnaires and skin oil measurements
Skin biopsies (samples) may be asked
12 study visits over 36 weeks
Not pregnant or breast feeding
Up to $415 in compensation for time and travel
For more information, please e-mail:
or call (617) 724-5329.